The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: ChAdOx-1-S

Australian Public Assessment Report

AusPAR

Australian public assessment report for Vaxzevria (ChAdOx-1-S) [PDF, 577.99 KB]

Australian public assessment report for Vaxzevria (ChAdOx-1-S) [Word, 2.54 MB]

Attachment: Product Information for Vaxzevria (ChAdOx-1-S) [PDF, 259.13 KB]

Attachment: Product Information for Vaxzevria (ChAdOx-1-S) [Word, 321.42 KB]

Device/Product Name

Vaxzevria

Active ingredients

ChAdOx-1-S

AusPAR Date

16 February 2022

Published

17 February 2022

Submission Number

PM-2021-05173-1-2

Submission Type

Major variation (change of dose regimen)

Decision

Approved for provisional registration